NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









TrueLab Biopharmaceutical

TrueLab Biopharmaceutical

Private
NingboHealthcare & Life Scienceshttps://www.truelab-bio.com/

Last Round

VC Round

Jun 22, 2026

Momentum

Top 1%

of companies Caplight tracks

Company Overview

TrueLab Biopharmaceutical is an immunology-driven biopharmaceutical company that discovers and develops differentiated therapies for immune-mediated inflammatory diseases using its proprietary TrueForge™ AI-powered R&D platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

antibody discoverydrug discoveryAI drug discoverybispecific antibodiesmonoclonal antibodiesgenerative AIin silico drug designimmunologyantibody engineeringTL1Abiotech licensingtranslational scienceAI biotechpharma R&Ddrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TrueLab Biopharmaceutical Comps

Public and private peers based on sector, stage, and business model.

TrueLab Biopharmaceutical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TrueLab Biopharmaceutical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 22, 2026

TrueLab Biopharmaceutical Investors

Notable investors and investment history

TrueLab Biopharmaceutical investors
InvestorRounds
Tencent ExplorationVC Round
Loyal Valley CapitalVC Round
Legend CapitalVC Round
Huagai CapitalVC Round
Bayland CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    $53M raised from Loyal Valley Capital and Tencent Exploration.

TrueLab Biopharmaceutical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TrueLab Biopharmaceutical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TrueLab Biopharmaceutical's valuation, stock price, and market status.

Firmographic Details

HeadquartersNingbo
Year Founded2023
Last FundingJun 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.